Follow-up investigations of tau protein and S-100B levels in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. (Q53370121)

13 May 2018

title

Follow-up investigations of tau protein and S-100B levels in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. (English)

1 reference

13 May 2018

0 references

7

1 reference

13 May 2018

Brit Mollenhauer

3

Brit Mollenhauer

1 reference

13 May 2018

4

Birgitt Wiese

1 reference

13 May 2018

Inga Zerr

8

Inga Zerr

1 reference

13 May 2018

Walter J Schulz-Schaeffer

9

Walter Schulz-Schaeffer

1 reference

13 May 2018

Markus Otto

12

Markus Otto

1 reference

13 May 2018

author name string

Lukas Cepek

1

1 reference

13 May 2018

Petra Steinacker

2

1 reference

13 May 2018

Barbara Ciesielczyk

5

1 reference

13 May 2018

Mirko Bibl

6

1 reference

13 May 2018

Hans A Kretzschmar

10

1 reference

13 May 2018

Sigrid Poser

11

1 reference

13 May 2018

publication date

30 March 2005

1 reference

13 May 2018

Dementia and Geriatric Cognitive Disorders

published in

1 reference

13 May 2018

volume

19

1 reference

13 May 2018

issue

5-6

1 reference

13 May 2018

page(s)

376-382

1 reference

13 May 2018

Accuracy and reliability of periodic sharp wave complexes in Creutzfeldt-Jakob disease

cites work

1 reference

Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease

21 January 2018

1 reference

Highly increased CSF tau protein and decreased beta-amyloid (1-42) in sporadic CJD: a discrimination from Alzheimer's disease?

21 January 2018

1 reference

A prospective study of CSF markers in 250 patients with possible Creutzfeldt-Jakob disease

21 January 2018

1 reference

The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies

21 January 2018

1 reference

Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease

21 January 2018

1 reference

Misleading results with the 14-3-3 assay for the diagnosis of Creutzfeldt-Jakob disease

21 January 2018

1 reference

Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease

21 January 2018

1 reference

Cerebrospinal fluid 14-3-3 protein: variability of sporadic Creutzfeldt-Jakob disease, laboratory standards, and quantitation

21 January 2018

1 reference

Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease

21 January 2018

1 reference

Diagnostic criteria for sporadic Creutzfeldt-Jakob disease

21 January 2018

1 reference

Ultrasensitive detection of pathological prion protein aggregates by dual-color scanning for intensely fluorescent targets

21 January 2018

1 reference

Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples.

21 January 2018

1 reference

High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype.

21 January 2018

1 reference

Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF.

21 January 2018

1 reference

Biological markers for therapeutic trials in Alzheimer's disease. Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease

21 January 2018

1 reference

Brain-specific proteins in cerebrospinal fluid for the diagnosis of neurodegenerative diseases

21 January 2018

1 reference

Creutzfeldt-Jakob disease: Patterns of worldwide occurrence and the significance of familial and sporadic clustering

21 January 2018

1 reference

Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease

21 January 2018

1 reference

Diagnosis of Creutzfeldt-Jakob disease by measurement of S100 protein in serum: prospective case-control study

21 January 2018

1 reference

High levels of nervous system-specific proteins in cerebrospinal fluid in patients with early stage Creutzfeldt-Jakob disease

21 January 2018

1 reference

Phosphorylated tau in cerebrospinal fluid as a marker for Creutzfeldt-Jakob disease

21 January 2018

1 reference

Beta-amyloid peptides in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.

21 January 2018

1 reference

Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt–Jakob disease

21 January 2018

1 reference

S-100 protein concentration in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000084708

1 reference

13 May 2018

1 reference

13 May 2018